$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

암 환자의 마약성 진통제로 인한 변비 치료법에 대한 문헌고찰
A Literature Review of Management for Opioid-Induced Constipation in Cancer Patients 원문보기

大韓癌韓醫學會誌 = Journal of Korean traditional oncology, v.25 no.2, 2020년, pp.37 - 49  

윤지현 (강동경희대학교한방병원 한방암센터 한방내과) ,  김은혜 (강동경희대학교한방병원 한방암센터 한방내과) ,  이지영 (강동경희대학교한방병원 한방암센터 한방내과) ,  윤성우 (강동경희대학교한방병원 한방암센터 한방내과)

Abstract AI-Helper 아이콘AI-Helper

Objective: Constipation is the most common adverse effect of opioid analgesic therapy in cancer patients. This can be associated with physical and emotional distress to cancer patients. The purpose of this study is to review the standard and alternative interventions of the management for opioid-ind...

주제어

표/그림 (2)

참고문헌 (51)

  1. Kim JH, Song H, Lee GW, Kang JH. Opioid withdrawal symptoms after conversion to oral oxycodone/naloxone in advanced cancer patients receiving strong opioids. Korean J Hosp Palliat Care 20(2):131-135, 2017 

  2. Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain. Curr Med Res Opin 21(10):1555-1566, 2005 

  3. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. Management of opioid side effects in cancer-related and chronic noncancer pain-A systematic review. J Pain 4(5):231-256, 2003 

  4. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician 11(2):S105-S120, 2008 

  5. Hong KS, Jung KW, Lee TH, Lee BE, Park SY, Shin JE, Kim SE, Park KS, Choi SC. Current issudes on the treatment of chronic constipation. Korean J Gastroentero 64(3):148-153, 2014 

  6. Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017 

  7. Boland JW, Boland, EG. Pharmacological therapies for opioid induced constipation in adults with cancer. BMJ 358:J3313. 2017. DOI:10.1136/bmj.j3313 

  8. Shin JE. Understanding the Rome IV : Functional constipation and anorectal disorders. Korean J Med 92(4):372-381, 2017 

  9. Larkin PJ, Cherny NI, La Carpia D, et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(4):111-125, 2018 

  10. Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag 5(3):137-144. 2009 

  11. Gatti A, Sabato AF. Management of Opioid-Induced Constipation in Cancer Patients. Clin Drug Investig 32:293-301, 2012 

  12. LoCasale RJ, Datto CJ, Margolis MK, Tack J, Coyne KS. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use. Int J Clin Pract. 69(12):1448-1456, 2015 

  13. Jeon HH, Park HJ. Diagnosis and treatment of constipation. Korean J Med 83(5):568-579, 2012 

  14. Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 44(8):1201-1209, 2001 

  15. Agra Y, Sacristan A, Gonzalez M, Ferrari M, Portugues A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage 15(1):1-7, 1998 

  16. Ahmedzai, SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid 2010:2407, 2010 

  17. Hawley PH, Byeon JJ. A comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer. J Palliat Med 11(4):575-581, 2008 

  18. Pitlick M, Fritz D. Evidence about the pharmacological management of constipation, part 2: implications for palliative care. Home Healthc Nurse 31(4):207-218, 2013 

  19. Selby W, Corte C. Managing constipation in adults. Aust Prescr 33:116-119, 2010 

  20. Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 43(2):306-313, 2012 

  21. Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Zuurmond WWA. The management of constipation in pallative care: Clinical practice recommendations. Palliat Med 22(7):796-807, 2008 

  22. National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 1. Fort Washington, PA: National Comprehensive Cancer Network; c2020. 2020 for Pallative care [cited 2020 Oct 19]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf 

  23. Siemens W, Becker G. Methylnaltrexone for opioid-induced constipation : Review and meta-analyses for objective plus subjective efficacy and safety outcomes. Ther Clin Risk Manag 12:401-412, 2016 

  24. Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 35(5):458-468, 2008 

  25. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid induced constipation in advanced illness. N Engl J Med 358(22):2332-2343, 2008 

  26. Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 7(1):39-46, 2009 

  27. Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension. J Palliat Med 18(7):593-600, 2015 

  28. Mori M, Yongli J, Kumar S, Ashikaga T, Ades S. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study. Int J Clin Oncol 22:397-404, 2017 

  29. Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain 154(9):1542-1550, 2013 

  30. Chey WD, Webster L, Sostek M, Lappalainen J, Barkder PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 370:2387-2396, 2014 

  31. Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, Suzuki Y, Narabayashi M, Boku N. Phase IIb, randomized, double blind, placebo-controlled study of naldemedine for the treatment of opioid induced constipation in patients with cancer. J Clin Oncol 35:1921-1928, 2017 

  32. Clemens KE, Quednau I, Klaschik E. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer. Int J Clin Pract 65:472-478, 2011 

  33. Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain 21:1528-1537, 2017 

  34. Dupoiron D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, Hopp M. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study. Eur J Pain 21:1485-1494, 2017 

  35. Chung VC, Wu X, Lu P, Hui EP, Zhang Y, Zhang AL, Lau AY, Zhao J, Fan M, Ziea ET, Ng BF, Wong SY, Wu JC. Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis. Medicine (Baltimore) 95(7):e2793, 2016. doi: 10.1097/MD.0000000000002793. 

  36. Gao YL, Li LY, Li PW. Clinical study on the effectiveness of Yi-Qi-Run-Chang Method for opioids induced constipation. J Trad Chin Med Emergency 19(4);585-586, 2016 

  37. Chen CM, Lin LZ, Zhang EX. Standardized treatment of Chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin J Integr Med 20(7):496-502, 2014 

  38. Zhang FL, Lin HS, He QY. Effect of electro-acupuncture in treating morphine sulfate caused constipation in tumor patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29(10):922-925, 2009 

  39. Zhu HD, Gong Z, Hu BW, Wei QL, Kong J, Peng CB. The efficacy and safety of transcutaneous acupoint interferential current stimulation for cancer pain patients with opioid-induced constipation: A prospective randomized controlled study. Integr Cancer Ther 17(2):437-443, 2018 

  40. Cai H, Zhou Q, Bao G, Kong X, Gong LY. Transcutaneous electrical nerve stimulation of acupuncture points enhances therapeutic effects of oral lactulose solution on opioid-induced constipation. J Int Med Res 47(12):6337-6348, 2019 

  41. Markland AD, Palsson O, Goode PS, Burgio KL, Busby-Whitehead J, Whitehead WE. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 108(5):796-803, 2013 

  42. Yang J, Wang HP, Zhou L, Xu CF. Effect of dietary fiber on constipation: A meta analysis. World J Gastroenterol 18(48):7378-7383, 2012 

  43. Lamas K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C. Effects of abdominal massage in management of constipation-a randomized controlled trial. Int J Nurs Stud 46(6):759-767, 2009 

  44. Park JU, Byun JI, Jung SH, Son IJ, Lee HS. Prophylactic laxative use and the compliance in relation to opioid-induced constipation. J Kor Soc Health-Syst Pharm 28(2):136-141, 2011 

  45. Wickham RJ. Managing Constipation in Adults With Cancer. J Adv Pract Oncol 8(2):149­161, 2017 

  46. Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ. Methylnaltrexone treatment of opioid-induced constipation in patients with advanved illness. J Pain Symptom Manage 38(5):683-690, 2009 

  47. Cho NH, Ryu BH. A study on Constipation. Korean J Orient Int Med 21(1):169-180, 2000 

  48. Jeon CH, Cho CS. Postoperative adhesive small bowel obstruction treated using acupuncture and moxibustion: A case report. Korean J Orient Int Med 41(2):233-240, 2020 

  49. Lee JY, Moon YJ, Chae HN, Moon G, Kwon YM, Baek DG. Two case reports using herbal medicine for long-term chronic constipation patients who take laxatives. Korean J Orient Int Med 39(5):1052-1060, 2018 

  50. Oh SD, Lim SM, Shin HS, Baek ET, Kim YT, Ra SY. The clinical review of bowel disorders following Parkinson's disease. Korean J Orient Int Med 22(4):735-742, 2001 

  51. Kang YL, Kim YJ, Hwang CW. The clinical study on 45 cases of patients of constipation caused by C.V.A who were treated with Bo-Riu Enema. Korean J Orient Int Med 21(2):329-336, 2000 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로